Cited by 54Nanoparticle-Based Drug DeliveryGlioma Diagnosis and TreatmentDendrimers and Hyperbranched Polymers

A polymeric temozolomide nanocomposite against orthotopic glioblastoma xenograft: tumor-specific homing directed by nestin

Prabhu, Suma, Goda, Jayant Sastri, Mutalik, Srinivas, Mohanty, Bhabani Shankar, Chaudhari, Pradip, Rai, Sharada, Udupa, Nayanabhirama, Rao, Bola Sadashiva Satish·2017·Nanoscale

Abstract

Nanocomposite for comprehensive pharmacokinetic and antitumor potential using transferrin for bypassing BBB and anti-nestin antibody as a homing moiety against glioma.

Integrity signals

Registry

Crossref · 10.1039/c7nr00305f

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Nanocomposites with transferrin and anti-nestin targeting ligands can deliver TMZ to intracerebral glioblastoma xenografts and present favorable pharmacokinetics and anti-cancer potential.

    “Such nanocomposites having targeting ligands could deliver TMZ to intracerebral glioblastoma xenografts and present favorable pharmacokinetics and anti-cancer potential.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Prabhu, S., Goda, J. S., Mutalik, S., Mohanty, B. S., Chaudhari, P., Rai, S., Udupa, N., & Rao, B. S. S.
Affiliations
  • Manipal Academy of Higher Education (IN)
  • Tata Memorial Hospital (IN)
Corresponding author
Rao, Bola Sadashiva Satish
Venue
Nanoscale
Published
2017
Volume
9
Issue
30
Pages
10919-10932
ISSN
  • 2040-3364 (ISSN-L)
  • 2040-3372
OpenAlex
W2727346589
Cited by
54
References
3
Citations by year
2026: 1 · 2025: 5 · 2024: 2 · 2023: 10 · 2022: 7 · 2021: 13 · 2020: 10 · 2019: 5 · 2018: 1
FWCI
1.58
Type
journal article
Language
en
Open access
closed
Locations
  • Nanoscale (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
  • Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
Keywords
glioblastoma, temozolomide, polymer nanocomposites, superparamagnetic iron oxide nanoparticles, targeted drug delivery, blood-brain barrier permeability, transferrin, Tween 80, orthotopic xenograft, sustained drug release, tumor targeting, magnetic nanoparticles, SPECT/CT imaging
MeSH terms
Temozolomide, Animals, Blood-Brain Barrier, Brain Neoplasms, Dacarbazine, Ferric Compounds, Glioblastoma, Humans, Mice, Inbred BALB C, Mice, SCID, Mice, Inbred NOD, Xenograft Model Antitumor Assays, Cell Line, Tumor, Nanoparticles, Nanocomposites, Nestin, Heterografts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review